Page 14 of 19 · 454 questions tagged vendor-vetting.
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I am asking for verification rather than opinion, ideally with something I can…
Setup, so nobody has to ask: cagrilintide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
The particulars: SWB · Bachem Holding (Suzhou). I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I am working with: Homopeptide · tirzepatide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
The lane and the lead time matter as much as the material for what I am doing. I want a method I can write down and repeat, not a rule of thumb. I would rather…
Conditions: 97.1% · oral semaglutide · QSC. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
What I am working with: QSC · mazdutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…
What I am working with: Homopeptide · oral semaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
The case in front of me: MKM · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
Setup, so nobody has to ask: oral semaglutide · chromatogram. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Setup, so nobody has to ask: MKM · Tianjin Finder Chemical. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
Concretely: 96.4% · oral semaglutide · QSC. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
The case in front of me: JEEP · retatrutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and…
Conditions: purity figure · SWB. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the method…
Details up front: 97.9% · dulaglutide · SSA. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I can parse the result. I am less sure what it licenses me to conclude. I…
The specifics, since they change the answer: Janoshik · Flourishglobal Peptide Biotech. This is presented as though it settles something, and I am not convinced it…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
The method section is present, which is unusual enough that I want to make use of it. This is one of those things that everyone repeats and nobody derives. This…
What I have: 97.1% · dulaglutide · MKM. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Setup, so nobody has to ask: SGN · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
For reference: 99.1% · semaglutide · WWB. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want to know whether there is evidence behind this or only…
The particulars: 99.1% · survodutide · KP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…